N-methyl-D-aspartate Receptor Subtypes: Multiple Roles in Excitotoxicity and Neurological Disease
暂无分享,去创建一个
[1] Won-Seok Choi,et al. Phosphorylation of p38 MAPK Induced by Oxidative Stress Is Linked to Activation of Both Caspase-8- and -9-mediated Apoptotic Pathways in Dopaminergic Neurons* , 2004, Journal of Biological Chemistry.
[2] D. Standaert,et al. Rationale for and use of NMDA receptor antagonists in Parkinson's disease. , 2004, Pharmacology & therapeutics.
[3] M. Fehlings,et al. Dual Neuroprotective Signaling Mediated by Downregulating Two Distinct Phosphatase Activities of PTEN , 2004, The Journal of Neuroscience.
[4] E. Kandel,et al. Loss of Presenilin Function Causes Impairments of Memory and Synaptic Plasticity Followed by Age-Dependent Neurodegeneration , 2004, Neuron.
[5] Michael W. Salter,et al. Src kinases: a hub for NMDA receptor regulation , 2004, Nature Reviews Neuroscience.
[6] T. Babb,et al. Mechanisms of epileptogenicity in cortical dysplasias , 2004, Neurology.
[7] Sheng-tian Li,et al. Critical Role of Calpain-mediated Cleavage of Calcineurin in Excitotoxic Neurodegeneration* , 2004, Journal of Biological Chemistry.
[8] R. Rissman,et al. Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology , 2004, Neurobiology of Disease.
[9] H. Tse,et al. Structure–activity analysis of a novel NR2C/NR2D‐preferring NMDA receptor antagonist: 1‐(phenanthrene‐2‐carbonyl) piperazine‐2,3‐dicarboxylic acid , 2004, British journal of pharmacology.
[10] K. Hoyt,et al. CRE-Mediated Transcription Is Increased in Huntington's Disease Transgenic Mice , 2004, The Journal of Neuroscience.
[11] M. MacDonald,et al. Enhanced Akt Signaling Is an Early Pro-survival Response That Reflects N-Methyl-D-aspartate Receptor Activation in Huntington's Disease Knock-in Striatal Cells* , 2003, Journal of Biological Chemistry.
[12] R. Neumar,et al. Selective Activation Induced Cleavage of the NR2B Subunit by Calpain , 2003, The Journal of Neuroscience.
[13] A. Periasamy,et al. Nitric-oxide-induced depolarization of neuronal mitochondria: implications for neuronal cell death , 2003, Molecular and Cellular Neuroscience.
[14] L. Raymond,et al. Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease , 2003, Neurobiology of Aging.
[15] E. Ziff,et al. NMDA receptor regulation of nNOS phosphorylation and induction of neuron death , 2003, Neurobiology of Aging.
[16] Yehezkel Ben-Ari,et al. The NMDA Receptor Is Coupled to the ERK Pathway by a Direct Interaction between NR2B and RasGRF1 , 2003, Neuron.
[17] E. Nagata,et al. Akt as a mediator of cell death , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. Feldman,et al. Treatment of Alzheimer's disease; current status and new perspectives , 2003, The Lancet Neurology.
[19] C. Parsons,et al. Expression of Polyglutamine-expanded Huntingtin Induces Tyrosine Phosphorylation of N-Methyl-D-aspartate Receptors* , 2003, Journal of Biological Chemistry.
[20] G. Fiskum,et al. Mitochondrial Mechanisms of Neural Cell Death and Neuroprotective Interventions in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.
[21] H. Tokumitsu,et al. Post-synaptic density-95 promotes calcium/calmodulin-dependent protein kinase II-mediated Ser847 phosphorylation of neuronal nitric oxide synthase. , 2003, The Biochemical journal.
[22] P. Spano,et al. Regulation of Dopamine D1 Receptor Trafficking and Desensitization by Oligomerization with Glutamate N-Methyl-D-aspartate Receptors* , 2003, Journal of Biological Chemistry.
[23] W. Löscher,et al. N-methyl-d-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy , 2003, Neuroscience.
[24] K. Storey,et al. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress , 2003, Journal of Experimental Biology.
[25] M. Billingsley,et al. Calcium-dependent interaction of calcineurin with bcl-2 in neuronal tissue , 2003, Neuroscience.
[26] D. Chuang,et al. Lithium‐induced inhibition of Src tyrosine kinase in rat cerebral cortical neurons: a role in neuroprotection against N‐methyl‐D‐aspartate receptor‐mediated excitotoxicity , 2003, FEBS letters.
[27] S. J. Tavalin,et al. Mapping the Protein Phosphatase-2B Anchoring Site on AKAP79 , 2002, The Journal of Biological Chemistry.
[28] Yitao Liu,et al. Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions , 2002, Science.
[29] M. di Luca,et al. Lack of PSD‐95 drives hippocampal neuronal cell death through activation of an αCaMKII transduction pathway , 2002, The European journal of neuroscience.
[30] R. Malinow,et al. Ras and Rap Control AMPA Receptor Trafficking during Synaptic Plasticity , 2002, Cell.
[31] R. V. Omkumar,et al. Sequence determinants on the NR2A and NR2B subunits of NMDA receptor responsible for specificity of phosphorylation by CaMKII. , 2002, Biochimica et biophysica acta.
[32] A. A. Parsons,et al. The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury. , 2002, European journal of pharmacology.
[33] T. Akiyama,et al. SPAL, a Rap‐specific GTPase activating protein, is present in the NMDA receptor‐PSD‐95 complex in the hippocampus , 2002, Genes to cells : devoted to molecular & cellular mechanisms.
[34] G. Avanzini,et al. αCaMKII and NMDA‐Receptor Subunit Expression in Epileptogenic Cortex from Human Periventricular Nodular Heterotopia , 2002, Epilepsia.
[35] H. Bading,et al. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways , 2002, Nature Neuroscience.
[36] T. Shimahara,et al. Alzheimer Amyloid β-Peptide Inhibits the Late Phase of Long-Term Potentiation through Calcineurin-Dependent Mechanisms in the Hippocampal Dentate Gyrus , 2002, Neurobiology of Learning and Memory.
[37] Y. Auberson,et al. 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. , 2002, Bioorganic & medicinal chemistry letters.
[38] M. Vemuri,et al. Calpain activation and α-spectrin cleavage in rat brain by ethanol , 2002, Neuroscience Letters.
[39] L. Raymond,et al. Increased Sensitivity to N-Methyl-D-Aspartate Receptor-Mediated Excitotoxicity in a Mouse Model of Huntington's Disease , 2002, Neuron.
[40] D. Lynch,et al. Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. , 2002, The Journal of pharmacology and experimental therapeutics.
[41] T. Bliss,et al. Brain-Derived Neurotrophic Factor Induces Long-Term Potentiation in Intact Adult Hippocampus: Requirement for ERK Activation Coupled to CREB and Upregulation of Arc Synthesis , 2002, The Journal of Neuroscience.
[42] Hiroto Takahashi,et al. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits , 2002, Nature.
[43] Hans Forssberg,et al. Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[44] J. Tsien,et al. Differential effects of enrichment on learning and memory function in NR2B transgenic mice , 2001, Neuropharmacology.
[45] D. Lynch,et al. NMDA receptor pharmacology: perspectives from molecular biology. , 2001, Current drug targets.
[46] M. Sheng,et al. Regulation of Dendritic Spine Morphology by SPAR, a PSD-95-Associated RapGAP , 2001, Neuron.
[47] F. Castellino,et al. The Amino Acid Residue at Sequence Position 5 in the Conantokin Peptides Partially Governs Subunit-selective Antagonism of RecombinantN-Methyl-d-aspartate Receptors* , 2001, The Journal of Biological Chemistry.
[48] Paul De Koninck,et al. Interaction with the NMDA receptor locks CaMKII in an active conformation , 2001, Nature.
[49] G. Liao,et al. Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current. , 2001, Molecular pharmacology.
[50] I. Módy,et al. Kindling induces transient NMDA receptor-mediated facilitation of high-frequency input in the rat dentate gyrus. , 2001, Journal of neurophysiology.
[51] M. di Luca,et al. Hippocampal Synaptic Plasticity Involves Competition between Ca2+/Calmodulin-Dependent Protein Kinase II and Postsynaptic Density 95 for Binding to the NR2A Subunit of the NMDA Receptor , 2001, The Journal of Neuroscience.
[52] S. Kassis,et al. SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. , 2001, The Journal of pharmacology and experimental therapeutics.
[53] Michael R. Hayden,et al. Mutant Huntingtin Enhances Excitotoxic Cell Death , 2001, Molecular and Cellular Neuroscience.
[54] S. Venneti,et al. NMDA and Glutamate Evoke Excitotoxicity at Distinct Cellular Locations in Rat Cortical Neurons In Vitro , 2000, The Journal of Neuroscience.
[55] R. Tremblay,et al. Transient NMDA Receptor Inactivation Provides Long-Term Protection to Cultured Cortical Neurons from a Variety of Death Signals , 2000, The Journal of Neuroscience.
[56] S. Donevan,et al. Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors. , 2000, Molecular pharmacology.
[57] J. Prehn,et al. Delayed Mitochondrial Dysfunction in Excitotoxic Neuron Death: Cytochrome c Release and a Secondary Increase in Superoxide Production , 2000, The Journal of Neuroscience.
[58] S. Larner,et al. p38 Map Kinase Mediates Bax Translocation in Nitric Oxide–Induced Apoptosis in Neurons , 2000, The Journal of cell biology.
[59] G. Cole,et al. Activation of Calpain I Converts Excitotoxic Neuron Death into a Caspase-independent Cell Death* , 2000, The Journal of Biological Chemistry.
[60] M. Baudry,et al. Calpain-mediated degradation of PSD-95 in developing and adult rat brain , 2000, Neuroscience Letters.
[61] M. Bennett,et al. Protein kinase C potentiation of N-methyl-D-aspartate receptor activity is not mediated by phosphorylation of N-methyl-D-aspartate receptor subunits. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[62] T. Shea,et al. Free PKC catalytic subunits (PKM) phosphorylate tau via a pathway distinct from that utilized by intact PKC , 1999, Brain Research.
[63] D. Fass,et al. Emergence of excitotoxicity in cultured forebrain neurons coincides with larger glutamate-stimulated [Ca2+]i increases and NMDA receptor mRNA levels , 1999, Brain Research.
[64] S. R. Datta,et al. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. , 1999, Science.
[65] C. Hisatsune,et al. Phosphorylation–dependent interaction of the N‐methyl‐ d‐aspartate receptor ε2 subunit with phosphatidylinositol 3‐kinase , 1999 .
[66] L. Raymond,et al. Subtype-Dependence of NMDA Receptor Channel Open Probability , 1999, The Journal of Neuroscience.
[67] M. di Luca,et al. αCaMKII binding to the C‐terminal tail of NMDA receptor subunit NR2A and its modulation by autophosphorylation , 1999, FEBS letters.
[68] J. Macdonald,et al. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. , 1999, Science.
[69] G. Westbrook,et al. The Incorporation of NMDA Receptors with a Distinct Subunit Composition at Nascent Hippocampal Synapses In Vitro , 1999, The Journal of Neuroscience.
[70] L. Raymond,et al. Subtype‐Specific Enhancement of NMDA Receptor Currents by Mutant Huntingtin , 1999, Journal of neurochemistry.
[71] J C Reed,et al. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. , 1999, Science.
[72] R. Dingledine,et al. The glutamate receptor ion channels. , 1999, Pharmacological reviews.
[73] T. Peng,et al. Privileged access to mitochondria of calcium influx through N-methyl-D-aspartate receptors. , 1998, Molecular pharmacology.
[74] M. Kennedy,et al. A Synaptic Ras-GTPase Activating Protein (p135 SynGAP) Inhibited by CaM Kinase II , 1998, Neuron.
[75] R. Huganir,et al. SynGAP: a Synaptic RasGAP that Associates with the PSD-95/SAP90 Protein Family , 1998, Neuron.
[76] S. Vicini,et al. Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons , 1998, The Journal of physiology.
[77] K. Mikoshiba,et al. Phosphorylation-dependent Regulation ofN-Methyl-d-aspartate Receptors by Calmodulin* , 1997, The Journal of Biological Chemistry.
[78] D. Green,et al. The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.
[79] D. Bredt,et al. Cloning and Characterization of Postsynaptic Density 93, a Nitric Oxide Synthase Interacting Protein , 1996, The Journal of Neuroscience.
[80] J. Penney,et al. Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus. , 1996, Brain research. Molecular brain research.
[81] A. F. Schinder,et al. Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity , 1996, The Journal of Neuroscience.
[82] R. Huganir,et al. SAP102, a Novel Postsynaptic Protein That Interacts with NMDA Receptor Complexes In Vivo , 1996, Neuron.
[83] M. Sheng,et al. Heteromultimerization and NMDA Receptor-Clustering Activity of Chapsyn-110, a Member of the PSD-95 Family of Proteins , 1996, Neuron.
[84] T. Dawson,et al. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[85] M. Sheng,et al. Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[86] J. Greene,et al. Manipulation of Membrane Potential Modulates Malonate‐Induced Striatal Excitotoxicity In Vivo , 1996, Journal of neurochemistry.
[87] M. Goldberg,et al. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[88] T. Yagi,et al. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit , 1995, Nature.
[89] B. Sakmann,et al. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors , 1994, Neuron.
[90] S. Snyder,et al. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[91] I. Módy,et al. Properties of NMDA receptor channels in neurons acutely isolated from epileptic (kindled) rats , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[92] R. Siman,et al. Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[93] D. Choi. Ionic dependence of glutamate neurotoxicity , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[94] G. Graveland,et al. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.
[95] William Holmes,et al. Models of Calmodulin Trapping and CaM Kinase II Activation in a Dendritic Spine , 2004, Journal of Computational Neuroscience.
[96] A. A. Parsons,et al. The selective p 38 inhibitor SB-239063 protects primary neurons from 2 mild to moderate excitotoxic injury 3 , 2002 .
[97] M. Vemuri,et al. Calpain activation and alpha-spectrin cleavage in rat brain by ethanol. , 2002, Neuroscience letters.
[98] C. Hisatsune,et al. Phosphorylation-dependent interaction of the N-methyl-D-aspartate receptor epsilon 2 subunit with phosphatidylinositol 3-kinase. , 1999, Genes to cells : devoted to molecular & cellular mechanisms.
[99] T. Dawson,et al. Nitric oxide in neurodegeneration. , 1998, Progress in brain research.
[100] Jianhong Luo,et al. The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). , 1997, Molecular pharmacology.
[101] T. Yagi,et al. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. , 1995, Nature.